(Rac) -Ruxolitinib-d9
(Rac) -Ruxolitinib D9 ((Rac) -INCB18424 D9) is the deuterium labeled (Rac) -Ruxolitinib. (Rac) -Ruxolitinib is a JAK2 inhibitor[1].
Product Specifications
CAS Number
[2469553-67-9]
Product Name Alternative
(Rac) -INCB18424-d9; Ruxotinib racemate-d9
UNSPSC
12352005
Target
Isotope-Labeled Compounds; JAK
Type
Isotope-Labeled Compounds
Related Pathways
Epigenetics; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.44
Solubility
10 mM in DMSO
Smiles
N#CCC(C1([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H])N2C=C(C=N2)C3=C4C(NC=C4)=NC=N3
Molecular Formula
C17H9D9N6
Molecular Weight
315.42
References & Citations
[1]Yaoyu CHEN, et al. Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor. Patent WO2021102258A1|[2]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
040283 200 µL
POTEH, NT (POTEH, A26C3, ACTBL1, POTE22, POTE ankyrin domain family member H, ANKRD26-like family C member 3, Prostate, ovary, testis-expressed protein on chromosome 22)
Sign In for Pricing
View Details 
MBS1138025-01 0.02 mg (E-Coli)
Recombinant Enterobacteria phage T4 Deoxycytidylate deaminase (CD)
Sign In for Pricing
View Details